MedPath

UNIVERSITY OF EDINBURGH

🇬🇧United Kingdom
Ownership
-
Established
1583-01-01
Employees
-
Market Cap
-
Website
https://www.ed.ac.uk

Clinical Trials

370

Active:17
Completed:268

Trial Phases

6 Phases

Early Phase 1:10
Phase 1:4
Phase 2:24
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (206 trials with phase data)• Click on a phase to view related trials

Not Applicable
141 (68.4%)
Phase 2
24 (11.7%)
Phase 4
16 (7.8%)
Phase 3
11 (5.3%)
Early Phase 1
10 (4.9%)
Phase 1
4 (1.9%)

Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia

Not Applicable
Recruiting
Conditions
18F-FDG PET/CT
Cold Exposure
Brown Adipose Tissue
First Posted Date
2025-07-02
Last Posted Date
2025-07-09
Lead Sponsor
University of Edinburgh
Target Recruit Count
12
Registration Number
NCT07048405
Locations
🇬🇧

Royal Infirmary of Edinburgh, Edinburgh, United Kingdom

Mechanisms of Myocardial Injury and Ischemia in Patients With Rapid Atrial Fibrillation

Recruiting
Conditions
Atrial Fibrillation (AF)
First Posted Date
2025-04-30
Last Posted Date
2025-06-11
Lead Sponsor
University of Edinburgh
Target Recruit Count
300
Registration Number
NCT06951100
Locations
🇬🇧

Royal Infirmary of Edinburgh, Edinburgh, East Of England, United Kingdom

Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department with Chest Pain: a Co-Production Approach. Phase 2.

Not Applicable
Not yet recruiting
Conditions
Cardiovascular Diseases
First Posted Date
2025-03-30
Last Posted Date
2025-03-30
Lead Sponsor
University of Edinburgh
Target Recruit Count
118
Registration Number
NCT06903442

Dual Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)

Phase 2
Recruiting
Conditions
Large Vessel Vasculitis
Giant Cell Arteritis (GCA)
Takayasu Arteritis
Interventions
First Posted Date
2025-03-20
Last Posted Date
2025-06-05
Lead Sponsor
University of Edinburgh
Target Recruit Count
60
Registration Number
NCT06887062
Locations
🇬🇧

University of Edinburgh, Edinburgh, United Kingdom

A Study on Bedside Formate Assay as a Diagnostic Tool in Methanol Poisoning

Not yet recruiting
Conditions
Metabolic Acidosis
First Posted Date
2025-03-18
Last Posted Date
2025-03-18
Lead Sponsor
University of Edinburgh
Target Recruit Count
6120
Registration Number
NCT06881641
Locations
🇧🇩

Chittagong Medical College Hospital, Chittagong, Bangladesh

🇧🇩

Mag Osmania Medical College Hospital Sylhet, Sylhet, Bangladesh

🇮🇳

PGIEMR, Chandigarh, India

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 74
  • Next

News

Novel Non-Hormonal Male Contraceptive "Adam" Shows Two-Year Efficacy in Clinical Trials

A new non-hormonal male contraceptive implant called Adam has demonstrated effectiveness for at least two years in initial clinical trials, with no sperm detected in participants reaching the 24-month mark.

Antidepressants Linked to Increased Risk of Sudden Cardiac Death, Danish Study Reveals

New research from Denmark shows antidepressant use is associated with an increased risk of sudden cardiac death, with risk rising based on duration of exposure.

AI Advances in Breast Cancer Detection: New Technologies Show Promise for Earlier Diagnosis

AI technology developed at Washington University can analyze sequential mammograms to identify subtle tissue changes, predicting breast cancer risk 2.3 times more accurately than standard methods.

Breakthrough: Combined Drug Therapy Shows Near-Complete Elimination of Liver Cancer in Study

Scottish researchers discover that combining cladribine with lenvatinib nearly eradicates hepatocellular carcinoma tumors in groundbreaking preclinical study led by Professor Tom Bird.

Early Aortic Valve Intervention Fails to Show Benefit in Asymptomatic Patients with Severe Aortic Stenosis and Myocardial Fibrosis

A randomized clinical trial involving 224 patients revealed that early aortic valve intervention did not significantly reduce the composite outcome of all-cause death or unplanned aortic stenosis-related hospitalization.

EVOLVED Trial: Early Aortic Valve Replacement Fails to Show Mortality Benefit in Asymptomatic Patients with Fibrosis

The EVOLVED study found that early aortic valve replacement (AVR) in asymptomatic patients with myocardial fibrosis did not reduce all-cause mortality or unplanned aortic stenosis-related hospitalizations.

SGLT-2 Inhibitors Linked to Reduced Dementia Risk in Type 2 Diabetes Study

A new study suggests that Sodium-glucose cotransporter-2 (SGLT-2) inhibitors, used for treating type 2 diabetes, are associated with a lower risk of developing dementia.

© Copyright 2025. All Rights Reserved by MedPath